Sigma Planning Corp boosted its holdings in CVS Health Corp (NYSE:CVS) by 35.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,514 shares of the pharmacy operator’s stock after purchasing an additional 6,963 shares during the quarter. Sigma Planning Corp’s holdings in CVS Health were worth $2,156,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in CVS. Pathstone Family Office LLC increased its stake in CVS Health by 341.0% in the 2nd quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock valued at $2,353,000 after buying an additional 982 shares during the period. Fieldpoint Private Securities LLC increased its stake in CVS Health by 333.3% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 1,000 shares during the period. Arcadia Investment Management Corp MI increased its stake in CVS Health by 119.6% in the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after buying an additional 726 shares during the period. MPS Loria Financial Planners LLC acquired a new position in CVS Health in the 2nd quarter valued at $119,000. Finally, Gemmer Asset Management LLC increased its stake in CVS Health by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after buying an additional 200 shares during the period. Hedge funds and other institutional investors own 81.69% of the company’s stock.
Several equities analysts have issued reports on CVS shares. Royal Bank of Canada started coverage on shares of CVS Health in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price objective on the stock. Oppenheimer reissued a “buy” rating and issued a $95.00 price objective on shares of CVS Health in a research note on Monday, October 9th. Needham & Company LLC reaffirmed a “hold” rating on shares of CVS Health in a research note on Thursday, October 12th. SunTrust Banks set a $85.00 price target on shares of CVS Health and gave the stock a “buy” rating in a research note on Thursday, October 12th. Finally, Jefferies Group set a $86.00 price target on shares of CVS Health and gave the stock a “hold” rating in a research note on Wednesday, October 18th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $86.63.
Shares of CVS Health Corp (NYSE:CVS) opened at $79.44 on Wednesday. The company has a market cap of $80,470.00, a PE ratio of 16.41, a P/E/G ratio of 1.25 and a beta of 0.90. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.72. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67.
CVS Health (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm’s revenue was up 3.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.64 EPS. equities analysts anticipate that CVS Health Corp will post 5.89 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.52%. CVS Health’s dividend payout ratio (DPR) is 41.32%.
In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the transaction, the executive vice president now directly owns 15,556 shares in the company, valued at approximately $1,166,700. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.61% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: “Sigma Planning Corp Grows Position in CVS Health Corp (CVS)” was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://transcriptdaily.com/2018/01/17/sigma-planning-corp-grows-position-in-cvs-health-corp-cvs.html.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.